Cardiometabolic disease research is at a turning point. With diabetes, obesity, and NASH increasing in prevalence, cardiovascular research has evolved from a heart-centric approach to a more holistic multi-organ approach focusing on common mechanisms and pathways such as tissue metabolism, adipose tissue properties and gut microbiota. By connecting key opinion leaders in both academic and industrial fields, this symposium aims to address whether these discoveries can leverage new interactions to help identify the next wave of innovative cardiometabolic disease medicines.
|